Children to get free measles-rubella vaccination in 2017
The measles-rubella vaccine (MR) produced by Vietnam, which was clinically tested and proven safe and effective, will be used in the National Expanded Programme on Immunisation free of charge in 2017.
Hanoi (VNA) – The measles-𒉰rubella vaccine (MR) produced by Vietnam, which was clinically tested and proven saf༒e and effective, will be used in the National Expanded Programme on Immunisation free of charge in 2017.
This is the first vaccine that has been produced in Vietnam by the Ministry of Health’s Centre for Research and Production of Vaccines and Biology (POLYVAC) under a technology-transfer project funded by the Japan International Co-operation Agency (JICA).
According POLYVAC Director Nguyen Dang Hien, the project started in May 2013 with a total cost of 700 million JPY (6.7 million USD). It targets a combined MR vaccine meeting the Good Manufacturing Practices standard of the World Health Organisation (WHO).
In March 2016, with the assistance of Japanese experts and efforts of the centre’s staff, the measles-rubella vaccine was clinically tested and proven safe and effective, Hien said.
Specifically, the vaccine has been tested on 756 healthy people aged between 1-45 in the northern provinces of Ha Nam and Hoa Binh.
The Science Technology and Training Administration (STTA) has verified that the measles-rubella vaccine produced by the centre has met the requirements in terms of safety and immunity.
Since the project began, the Japanese side’s technology transfer unit – Kitasato Daiichi Sankyo Vaccine (KDSV) has sent 197 experts to Vietnam to support POLYVAC in producing the vaccine and received 36 staff from the centre for training in its plant in Japan.
Hien said the project’s success helps Vietnam proactively prevent diseases and protect the people’s health.
With its current capacity of 7.5 million doses per year, the centre can fully meet the domestic vaccine demand, even export in the future.
In 2015, the WHO certified that Vietnam has a fully-equipped national regulatory authority (NRA) system that ensures the safety and efficacy of vaccines produced and used in Vietnam.
Currently, Vietnam is among 25 nations that can produce vaccines in the world, and four in Asia that can produce the measles-rubella vaccine, following Japan, India, and China.-VNA
A combined measles-rubella vaccine is expected to be available for children aged nine months to 14 years within a year or two, according to the Ho Chi Minh City Pasteur Institute.
The Ministry of Health (MOH) has approved a new recommended schedule of the National Expanded Programme on Immunisation, in which the second measles shot given to children aged 18 months old will be replaced by a measles-rubella vaccine.
The health sector’s national target programmes between 2011-2015 helped raise public awareness of the importance of individual and community health care.
Vietnam has successfully produced a combined measles-rubella vaccine as part of a project with co-operation from the Japan International Co-operation Agency (JICA).
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Illustrative image (Source: VNA)
